Abstract
Objective: Transsexual patients undergo therapy with high dose of androgens for the expressed purpose of gender reassignment. These patients then undergo oophorectomy with or without hysterectomy for the purposes of their gender reassignment. This treatment provides an in vivo model of the effects of a supra-physiological dose of androgens on the normal female genital tract-thus, providing the opportunity to further understand the role of androgens in modulating hormone receptor expression, changes in cellular proliferation, cell atrophy, ovulation, and the propensity to dysplastic change.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
